CY1109546T1 - Φαρμακο για την προληψη η θεραπεια της συχνουριας η της ουρικης ακρατειας - Google Patents
Φαρμακο για την προληψη η θεραπεια της συχνουριας η της ουρικης ακρατειαςInfo
- Publication number
- CY1109546T1 CY1109546T1 CY20091101275T CY091101275T CY1109546T1 CY 1109546 T1 CY1109546 T1 CY 1109546T1 CY 20091101275 T CY20091101275 T CY 20091101275T CY 091101275 T CY091101275 T CY 091101275T CY 1109546 T1 CY1109546 T1 CY 1109546T1
- Authority
- CY
- Cyprus
- Prior art keywords
- prevention
- treatment
- medicine
- incontinence
- frequency
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα ευρεσιτεχνία παρέχει φάρμακα χρήσιμα για την πρόληψη ή θεραπεία της συχνότητας ούρησης ή ακράτειας. Δηλαδή, η παρούσα ευρεσιτεχνία σχετίζεται με ένα φάρμακο, το οποίο περιλαμβάνει συνδυασμό παραγώγου φαινοξυοξικού οξέος που αναπαριστάται από τον ακόλουθο γενικό τύπο (I) (όπου R1 αναπαριστά μία υδροξυ-ομάδα ή μία κατώτερη αλκοξυ-ομάδα) ή ένα φαρμακευτικό άλας αυτού ή ένα υδρίτη ή επιδιαλυτωμένο χημικό σωματίδιο αυτού και έναν παρεμποδιστή αδρενο- υποδοχέα α1, που ασκεί ένα εξαιρετικό αποτέλεσμα στην μείωση της εσωτερικής πίεσης της ουροδόχου κύστης ή στην παράταση του διαστήματος ούρησης και χρησιμεύει για την πρόληψη ή θεραπεία της συχνότητας ούρησης ή ακράτειας.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2004/004000 WO2005092321A1 (ja) | 2004-03-24 | 2004-03-24 | 頻尿または尿失禁の予防または治療用医薬組成物 |
| EP05721012A EP1728508B1 (en) | 2004-03-24 | 2005-03-17 | Medicine for prevention or treatment of frequent urination or urinary incontinence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1109546T1 true CY1109546T1 (el) | 2014-08-13 |
Family
ID=34993428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091101275T CY1109546T1 (el) | 2004-03-24 | 2009-12-04 | Φαρμακο για την προληψη η θεραπεια της συχνουριας η της ουρικης ακρατειας |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080242674A1 (el) |
| EP (1) | EP1728508B1 (el) |
| AT (1) | ATE442137T1 (el) |
| CA (1) | CA2559646A1 (el) |
| CY (1) | CY1109546T1 (el) |
| DE (1) | DE602005016534D1 (el) |
| DK (1) | DK1728508T3 (el) |
| ES (1) | ES2331369T3 (el) |
| PL (1) | PL1728508T3 (el) |
| PT (1) | PT1728508E (el) |
| SI (1) | SI1728508T1 (el) |
| WO (2) | WO2005092321A1 (el) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1769792A1 (de) * | 2005-09-30 | 2007-04-04 | Boehringer Ingelheim Pharma GmbH & Co.KG | Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden |
| FR2895259B1 (fr) * | 2005-12-22 | 2008-02-22 | Urosphere Sas | Methodes de traitement des incontinences urinaires |
| WO2008106125A2 (en) | 2007-02-26 | 2008-09-04 | Concert Pharmaceuticals, Inc. | Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists |
| EP2192903A4 (en) * | 2007-10-02 | 2010-09-29 | Dong A Pharm Co Ltd | COMPOSITION AND METHOD OF TREATMENT OR METHOD PREVENTING SYMPTOMS BENIGNER PROSTATE HYPERPLASIA AND LOWER HARN |
| EP2363397A4 (en) * | 2008-11-07 | 2012-07-11 | Dainippon Sumitomo Pharma Co | NEW THERAPEUTIC AGENT USEFUL FOR SYMPTOM OF LOWER URINARY TRACT |
| WO2013027806A1 (ja) * | 2011-08-25 | 2013-02-28 | キッセイ薬品工業株式会社 | 低活動膀胱の予防または治療用医薬組成物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6426517A (en) * | 1987-07-21 | 1989-01-27 | Sankyo Co | Remedy for dysuria |
| SE504276C2 (sv) * | 1993-12-30 | 1996-12-23 | Siko Medical Ab | Ventil avsedd att placeras i urinröret |
| US6262115B1 (en) * | 1995-05-22 | 2001-07-17 | Alza Coporation | Method for the management of incontinence |
| US20020143007A1 (en) * | 1996-02-02 | 2002-10-03 | Garvey David S. | Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| US6410554B1 (en) * | 1998-03-23 | 2002-06-25 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
| MY126489A (en) * | 1998-07-08 | 2006-10-31 | Kissei Pharmaceutical | Phenoxyacetic acid derivatives and medicinal compositions containing the same |
| JP3154710B1 (ja) * | 1999-08-09 | 2001-04-09 | 山之内製薬株式会社 | 下部尿路症治療剤 |
| IL141235A (en) * | 2000-02-09 | 2012-04-30 | Novartis Int Pharm Ltd | Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia |
| JP2001288115A (ja) * | 2001-02-07 | 2001-10-16 | Yamanouchi Pharmaceut Co Ltd | 下部尿路症治療剤 |
| KR20040052489A (ko) * | 2001-03-06 | 2004-06-23 | 셀러지 파마세우티칼스, 인크 | 비뇨생식기 장애 치료용 화합물 및 그 방법 |
| JP4132020B2 (ja) * | 2001-03-12 | 2008-08-13 | キッセイ薬品工業株式会社 | フェノキシ酢酸誘導体の製造中間体およびその使用方法 |
| JP2003055261A (ja) * | 2001-08-08 | 2003-02-26 | Pfizer Prod Inc | 製剤組合せ |
| HUP0401694A3 (en) * | 2001-09-13 | 2008-03-28 | Kissei Pharmaceutical | Crystal forms of a hydrochloride salt of a hydroxynorephedrine derivative, pharmaceutical compositions comprising thereof and use |
| MXPA06004625A (es) * | 2003-11-03 | 2006-06-27 | Boehringer Ingelheim Int | Composicion famaceutica que contiene un agonista de un adrenoceptor beta-3 y un antagonista alfa y/o un inhibidor de la 5-alfa-reductasa. |
| KR20070003968A (ko) * | 2004-03-05 | 2007-01-05 | 깃세이 야쿠힌 고교 가부시키가이샤 | 신경 장애에 따른 과활동 방광의 예방 또는 치료용 의약조성물 |
-
2004
- 2004-03-24 WO PCT/JP2004/004000 patent/WO2005092321A1/ja active Application Filing
-
2005
- 2005-03-17 WO PCT/JP2005/004825 patent/WO2005089742A1/ja not_active Application Discontinuation
- 2005-03-17 US US10/599,203 patent/US20080242674A1/en not_active Abandoned
- 2005-03-17 CA CA002559646A patent/CA2559646A1/en not_active Abandoned
- 2005-03-17 SI SI200530851T patent/SI1728508T1/sl unknown
- 2005-03-17 EP EP05721012A patent/EP1728508B1/en not_active Not-in-force
- 2005-03-17 AT AT05721012T patent/ATE442137T1/de active
- 2005-03-17 PT PT05721012T patent/PT1728508E/pt unknown
- 2005-03-17 DK DK05721012.2T patent/DK1728508T3/da active
- 2005-03-17 ES ES05721012T patent/ES2331369T3/es active Active
- 2005-03-17 PL PL05721012T patent/PL1728508T3/pl unknown
- 2005-03-17 DE DE602005016534T patent/DE602005016534D1/de active Active
-
2009
- 2009-12-04 CY CY20091101275T patent/CY1109546T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602005016534D1 (de) | 2009-10-22 |
| EP1728508B1 (en) | 2009-09-09 |
| ATE442137T1 (de) | 2009-09-15 |
| DK1728508T3 (da) | 2010-01-25 |
| WO2005092321A1 (ja) | 2005-10-06 |
| EP1728508A1 (en) | 2006-12-06 |
| CA2559646A1 (en) | 2005-09-29 |
| SI1728508T1 (sl) | 2010-01-29 |
| US20080242674A1 (en) | 2008-10-02 |
| PL1728508T3 (pl) | 2010-02-26 |
| ES2331369T3 (es) | 2009-12-30 |
| WO2005089742A1 (ja) | 2005-09-29 |
| EP1728508A4 (en) | 2008-02-13 |
| WO2005089742A8 (ja) | 2005-11-03 |
| PT1728508E (pt) | 2009-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109546T1 (el) | Φαρμακο για την προληψη η θεραπεια της συχνουριας η της ουρικης ακρατειας | |
| WO2006067165A3 (en) | Indolidone derivatives for the treatment or prevention of fibrotic diseases | |
| EP2639229A3 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
| FI943948A0 (fi) | Heterosykliset hiilihappojohdannaiset | |
| HK1062677A1 (en) | 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| WO2009063202A3 (en) | Use of crth2 antagonist compounds | |
| NO20051209L (no) | Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme | |
| EA200701504A1 (ru) | Индолы, пригодные для лечения воспалений | |
| UA85707C2 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
| MX2010001236A (es) | Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1). | |
| PL2229356T3 (pl) | 1,2-Dipodstawione pochodne 4-benzyloamino-pirolidyny jako inhibitory CETP użyteczne do leczenia chorób, takich jak hiperlipidemia lub stwardnienie tętnic | |
| EP2620145A3 (en) | 2,5-dihydroxybenzene compounds for the treatment of of cancer of an organ | |
| EA200600971A1 (ru) | Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона | |
| EP1627635A3 (en) | Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection | |
| SE0301232D0 (sv) | Novel use | |
| MY151072A (en) | Heteroaryl derivative | |
| DE602004005502D1 (de) | Comt-inhibitoren | |
| EA200800071A1 (ru) | Производные бензофуранила как ингибиторы 5-нт6-рецептора | |
| MA33619B1 (fr) | Agent thérapeutique pour des troubles de l'anxiété | |
| DE60216239T8 (de) | Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie | |
| BRPI0513549A (pt) | composições farmacêuticas para o tratamento de leishmaniose | |
| DE60127535D1 (de) | Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation | |
| TW200800978A (en) | Carbazole compound | |
| WO2006030322A3 (en) | Use of fla vone/fla vanone derivatives fn the treatment or prevention of respiratory conditions | |
| WO2008058995A3 (de) | Verwendung von cytohesin-inhibitoren zur chemischen induktion von langlebigkeit |